Coagulation Parameters: An Efficient Measure for Predicting the Prognosis and Clinical Management of Patients with COVID-19Article Published on 2020-10-282022-10-30 Journal: Journal of Clinical Medicine [Category] COVID-19, [키워드] abnormality acute respiratory syndrome affected clinical Clinical management Coagulation coagulation parameter cohort of patient coronavirus coronavirus disease COVID-19 D-dimer level efficient evaluate fibrinogen level global pandemic healthcare IQR measure median age men non-survivor pandemic Patient patients patients with COVID-19 performed Prognosis respiratory infection retrospective cohort study SARS-CoV-2 Spain Survivors with COVID-19 Wuhan, China [DOI] 10.3390/jcm9113482 PMC 바로가기 [Article Type] Article
Safety and Efficacy of Apixaban For Therapeutic Anticoagulation in Critically Ill ICU Patients with Severe COVID-19 Respiratory DiseaseOriginal Article Published on 2020-10-232022-10-29 Journal: TH Open: Companion Journal to Thrombosis and Haemostasis [Category] COVID-19, [키워드] acute respiratory distress anticoagulation apixaban Atrial fibrillation benefit bleeding bleeding event coagulation parameter Coagulation parameters Coagulopathy COVID-19 death Direct disease DOACs Efficacy evaluate evaluated follow-up period ICU ICU patient Ill incidence initiated intensive care LMWH low molecular weight major bleeding event material mechanical ventilation morbidity and mortality Mortality novel coronavirus disease obese oral anticoagulant Patient Prophylaxis remained renal dysfunction renal replacement therapy required respiratory Respiratory disease Result retrospective cohort study Safe Safety SARS-CoV-2 seeking severe COVID-19 severe COVID-19 disease study period subsequent syndrome thromboembolic disease Thromboembolic events thrombosis treated Treatment Trial unfractionated heparin Venous Thromboembolism VTE [DOI] 10.1055/s-0040-1720962 PMC 바로가기 [Article Type] Original Article
Unfractionated Heparin in SARS-CoV-2 Pneumonia: Ischemic Stroke Case ReportNeurology Published on 2020-09-252022-11-01 Journal: Frontiers in Neurology [Category] COVID-19, [키워드] anticoagulation coagulation parameter Coagulopathy Coronavirus disease 2019 COVID-19 Disseminated intravascular coagulation Effect heparin Hospitalized hypercoagulability hypercoagulable Ischemic Laboratory marker parameter Patient patient with COVID-19 Pneumonia proportion recent report SARS-CoV-2 severe COVID-19 stroke the patient Thromboembolic event Thromboembolism unfractionated heparin [DOI] 10.3389/fneur.2020.573356 PMC 바로가기 [Article Type] Neurology
Analysis of coagulation parameters in patients with COVID-19 in Shanghai, ChinaArticle Published on 2020-09-212023-07-14 Journal: Bioscience trends [Category] SARS, [키워드] coagulation parameter COVID-19 D-dimer fibrinogen SARS-CoV-2 [DOI] 10.5582/bst.2020.03086
SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19Research Published on 2020-09-042022-10-29 Journal: Journal of Hematology & Oncology [Category] COVID-19, SARS, [키워드] ACE2 ACE2 expression aggregates aggregation bind binding blood stream cardiovascular complications CD62P changes in Coagulation factors coagulation parameter condition correlated COVID-19 COVID-19 patient COVID-19 patients Critical Critically ill patient critically ill patients decrease demonstrated develop diagnosed with COVID-19 downstream ENhance evaluated Evidence Ex vivo expressed expression facilitate flow cytometry functional hACE2 healthy volunteers host cell receptor human Ace2 protein hyperactivity immunofluorescence in vitro in vivo inflammatory factors Inflammatory response inhibit SARS-CoV-2 investigated MAPK mice monoclonal antibody MPV Non-COVID-19 PAC-1 pathogenesis of COVID-19 pathway Platelet platelet activation Platelets priming pro-thrombotic Protein provided recombinant responsible Result risk RT-PCR SARS-CoV-2 SARS-CoV-2 RNA SARS-CoV-2 virus secretion serine protease spike stimulated thrombosis thrombotic event thrombus formation TMPRSS2 transfused transgenic transgenic mice Volume wild-type [DOI] 10.1186/s13045-020-00954-7 PMC 바로가기 [Article Type] Research
Early coagulation tests predict risk stratification and prognosis of COVID-19Research Paper Published on 2020-08-312022-10-28 Journal: Aging (Albany NY) [Category] COVID-19, MERS, [키워드] accompanied Admission article blood coagulation disorders calculated coagulation disorder coagulation parameter coagulation test Cochrane Library composite endpoint condition correlated COVID-19 COVID-19 patients D-dimer death Degradation determine disease severity elevated endpoints Final had no ICU IMPROVE Inclusion increased risk mean difference Meta-analysis outbreak Patient Platelet predict producing Prognosis Prothrombin time recognizing Research risk risk stratification searched SMD statistical statistically the disease therapy Web of Science worsening [DOI] 10.18632/aging.103581 PMC 바로가기 [Article Type] Research Paper
D-dimer surge and coagulation disorders in COVID-19 related pneumonia patients with cardiac injury A case series4800 Published on 2020-07-312022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] accompanied analyzed cardiac injury Case series case sery cause Cerebrovascular disease cerebrovascular diseases changes in characterized clinical clinical trial coagulation disorder coagulation disorders coagulation parameter collected COVID-19 COVID-19 patient criteria D-dimer D-dimer level D-dimer surge death defined disorder fibrinogen FIVE five COVID-19 patient higher risk Hospitalization Hypothesis In-hospital In-hospital death incubated Injury invasive ventilation management outcome Patient patients patients died Platelet Pneumonia Prothrombin time rapid increase reached reduced Registered Retrospective study severe coronavirus disease Support upper reference limit [DOI] 10.1097/MD.0000000000021513 PMC 바로가기 [Article Type] 4800
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for AnticoagulationReview Published on 2020-07-172022-10-31 Journal: Clinical and applied thrombosis/hemostasis : offic [Category] COVID-19, MERS, SARS, [키워드] Adapted addition Anticoagulant anticoagulation bleeding event can be used caused characterized coagulation parameter Coagulopathy complex COVID-19 cytokine d -dimer death decrease dosage dose effective Effects exaggerated inflammatory response Factor hematology IMPROVE incidence increase in Limited LMWH lung failure manifestation Microvascular thrombosis new coronavirus SARS-CoV-2 Novel coronavirus infection outcome parameter Patient patients patients with COVID-19 prognostic proportion rationale reduction in reported risk Sepsis severe COVID-19 manifestations severe COVID-19 patients shown Society Standard dose syndrome thrombosis [DOI] 10.1177/1076029620938149 PMC 바로가기 [Article Type] Review
Prominent Hypercoagulability Associated With Inflammatory State Among Cancer Patients With SARS-CoV-2 InfectionOncology Published on 2020-07-162022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] analyzed anticoagulant therapy anticoagulation Cancer cancer patient Cancer patients coagulation parameter COVID-19 Critical D-dimer D-dimer level General population hypercoagulability IL-6 IL-6 level ill patient IMPROVE Increased Inflammation MPV negative correlation Novel coronavirus PaO parameter Patient patients patients with COVID-19 PCT Pneumonia positively correlated potential benefit Prognosis Prominent reported SARS-CoV-2 SARS-COV-2 infection severe inflammation severity state survived therapy [DOI] 10.3389/fonc.2020.01345 PMC 바로가기 [Article Type] Oncology
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumoniaArticle Published on 2020-03-132023-06-15 Journal: Journal of thrombosis and haemostasis : JTH [Category] MERS, SARS, [키워드] coagulation parameter D‐dimer Disseminated intravascular coagulation fibrin degradation product novel coronavirus pneumonia [DOI] 10.1111/jth.14768 PMC 바로가기